But more EBRT patients had Gleason score of 2-6 or 8-10.

But more EBRT patients had Gleason score of 2-6 or 8-10. They make several generalizations from their data. For cancer related HRQoL, at 12 months, had more back from the RP group with baseline bowel and bladder function and had less bowel bother. EBRT patients showed better urinary and sexual function.

The significant observations include – : RP patients were more likely choice, Caucasian, college-educated, full-time work , married and be an annual income over $ 40,000. They were younger than the EBRT group . The two groups did not differ significantly in Charlson scores PSA at diagnosis, PSA after treatment and TNM stage.. The RP group also showed significant improvement after 12 months of bowel function and anger, and disturb less urine, but they showed a lower total urinary and sexual function and sexual bother more. Older age, Gleason score higher and higher TNM stage were associated with selection EBRT as treatment. And finally , they found no difference in satisfaction of care between the groups.

Related Quality Of Life And satisfaction with the care of older men for prostate cancer with either RP or EBRT TreatedUroToday – R. Continue reading “But more EBRT patients had Gleason score of 2-6 or 8-10.”

The research was supported by the National Institutes of Health.

The research was supported by the National Institutes of Health, the Lucile Packard Foundation for Children ‘s Health, the Damon Runyon Cancer Foundation, the California Institute for Regenerative Medicine, the Human Frontier Science Program, the European Molecular Biology Organization, the Fonds support de la Recherche Scientifique, the Leon Fredericq Foundation and the Leukemia and Lymphoma Society.

The researchers also looked to see whether there is a association between cannabis use and suicidal thoughts and anxiety. They reported that the results of these findings were less reliable.

Say about 20 percent of young people in the UK, they use cannabis at least once a week. Cannabis is the most common illegal substance in the United Kingdom and the United States. Theresa Moore, University of Bristol, Stanley Zammit, Cardiff University, and team carried out a meta-analysis of 35 studies, of to 2006. Continue reading “The research was supported by the National Institutes of Health.”

Page 2 of 212